Alerts will be sent to your verified email
Verify EmailMEDICO
Medico Remedies
|
Medicamen Biotech
|
Brooks Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
13.93 % | 6.92 % | -23.88 % |
5yr average Equity Multiplier
|
2.07 | 1.44 | 1.78 |
5yr Average Asset Turnover Ratio
|
1.49 | 0.55 | 0.6 |
5yr Avg Net Profit Margin
|
4.73 % | 8.69 % | -23.79 % |
Price to Book
|
6.42 | 1.92 | 3.95 |
P/E
|
38.86 | 43.02 | 0.0 |
5yr Avg Cash Conversion Cycle
|
53.33 Days | 49.75 Days | -10.34 Days |
Inventory Days
|
48.95 Days | 84.58 Days | 93.5 Days |
Days Receivable
|
129.15 Days | 139.4 Days | 66.75 Days |
Days Payable
|
124.28 Days | 264.75 Days | 179.8 Days |
5yr Average Interest Coverage Ratio
|
11.55 | 7.03 | -11.84 |
5yr Avg ROCE
|
20.03 % | 10.34 % | -15.03 % |
5yr Avg Operating Profit Margin
|
7.11 % | 15.51 % | -13.23 % |
5 yr average Debt to Equity
|
0.26 | 0.15 | 0.21 |
5yr CAGR Net Profit
|
31.26 % | -11.57 % | 0.22 % |
5yr Average Return on Assets
|
6.88 % | 4.73 % | -14.62 % |
Shareholdings
|
|||
Promoter Holding
|
62.59 % | 40.46 % | 52.62 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-10.75 % | -3.14 % | -13.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 9.9 % |
Medico Remedies
|
Medicamen Biotech
|
Brooks Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|